FERIMZONE


UNII	82Y473840Y
Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	GOWLARCWZRESHU-AQTBWJFISA-N
Smiles	C\C(=N\Nc1nc(C)cc(C)n1)\c2ccccc2C
InChI	InChI=1S/C15H18N4/c1-10-7-5-6-8-14(10)13(4)18-19-15-16-11(2)9-12(3)17-15/h5-9H,1-4H3,(H,16,17,19)/b18-13-

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C15H18N4
Molecular Weight	254.33
AlogP	3.22
Hydrogen Bond Acceptor	4.0
Hydrogen Bond Donor	1.0
Number of Rotational Bond	3.0
Polar Surface Area	50.17
Molecular species	NEUTRAL
Aromatic Rings	2.0
Heavy Atoms	19.0

Assay Description	Organism	Bioactivity
Fungicidal activity against Magnaporthe oryzae in rice seedlings assessed as control of rice blast at 500 ppm by curative foliar treatment	Magnaporthe oryzae	100.0 %
Fungicidal activity against Magnaporthe oryzae in rice seedlings assessed as control of rice blast at 500 ppm by preventive foliar treatment	Magnaporthe oryzae	99.0 %
Fungicidal activity against Fusarium fujikuroi by agar dilution method	Fusarium fujikuroi	100.0 ug.mL-1
Fungicidal activity against Fusarium fujikuroi assessed as infected rice seedlings in seed disinfection against bakanae disease at 1000 ppm by soaking method	Fusarium fujikuroi	None
In vivo fungicidal activity against Rhizoctonia solani in rice seedlings assessed as control of sheath blight disease at 500 ppm by curative foliar treatment	Rhizoctonia solani	100.0 %
Fungicidal activity against Rhizoctonia solani by agar dilution method	Rhizoctonia solani	50.0 ug.mL-1
Fungicidal activity against Magnaporthe salvinii by agar dilution method	Magnaporthe salvinii	1.56 ug.mL-1
Fungicidal activity against Bipolaris oryzae by agar dilution method	Bipolaris oryzae	25.0 ug.mL-1
Fungicidal activity against Magnaporthe oryzae by agar dilution method	Magnaporthe oryzae	3.12 ug.mL-1
Fungicidal activity against Magnaporthe oryzae Cav. race 003 assessed as rice blast disease control at 2 ppm foliar application for 24 hr before inoculation by preventive manner	Magnaporthe oryzae	30.0 %
Fungicidal activity against Magnaporthe oryzae Cav. race 003 assessed as rice blast disease control at 7.8 ppm foliar application for 24 hr before inoculation by preventive manner	Magnaporthe oryzae	50.0 %
Fungicidal activity against Magnaporthe oryzae Cav. race 003 assessed as rice blast disease control at 31.3 ppm foliar application for 24 hr before inoculation by preventive manner	Magnaporthe oryzae	90.0 %
Fungicidal activity against Magnaporthe oryzae Cav. race 003 assessed as rice blast disease control at 125 ppm foliar application for 24 hr before inoculation by preventive manner	Magnaporthe oryzae	97.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2286690
FDA SRS	82Y473840Y
PubChem	9013425
SureChEMBL	SCHEMBL22254

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).